The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by RNA-based Biopharmaceuticals Revenue 1.5 Market Analysis by Type 1.5.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Therapeutics 1.5.3 Vaccines 1.6 Market by Application 1.6.1 Global RNA-based Biopharmaceuticals Market Share by Application: 2021-2026 1.6.2 Cancer 1.6.3 Diabetes 1.6.4 Tuberculosis 1.6.5 Cardiovascular Diseases 1.6.6 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global RNA-based Biopharmaceuticals Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global RNA-based Biopharmaceuticals Market Players Profiles 3.1 Pfizer 3.1.1 Pfizer Company Profile 3.1.2 Pfizer RNA-based Biopharmaceuticals Product Specification 3.1.3 Pfizer RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Dicerna 3.2.1 Dicerna Company Profile 3.2.2 Dicerna RNA-based Biopharmaceuticals Product Specification 3.2.3 Dicerna RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Abbott Laboratories 3.3.1 Abbott Laboratories Company Profile 3.3.2 Abbott Laboratories RNA-based Biopharmaceuticals Product Specification 3.3.3 Abbott Laboratories RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Roche 3.4.1 Roche Company Profile 3.4.2 Roche RNA-based Biopharmaceuticals Product Specification 3.4.3 Roche RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Calimmune Inc 3.5.1 Calimmune Inc Company Profile 3.5.2 Calimmune Inc RNA-based Biopharmaceuticals Product Specification 3.5.3 Calimmune Inc RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Sanofi-Aventis 3.6.1 Sanofi-Aventis Company Profile 3.6.2 Sanofi-Aventis RNA-based Biopharmaceuticals Product Specification 3.6.3 Sanofi-Aventis RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Quark 3.7.1 Quark Company Profile 3.7.2 Quark RNA-based Biopharmaceuticals Product Specification 3.7.3 Quark RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Benitec Biopharma 3.8.1 Benitec Biopharma Company Profile 3.8.2 Benitec Biopharma RNA-based Biopharmaceuticals Product Specification 3.8.3 Benitec Biopharma RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Arrowhead Pharmaceuticals 3.9.1 Arrowhead Pharmaceuticals Company Profile 3.9.2 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Specification 3.9.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Gradalis 3.10.1 Gradalis Company Profile 3.10.2 Gradalis RNA-based Biopharmaceuticals Product Specification 3.10.3 Gradalis RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Tekmira 3.11.1 Tekmira Company Profile 3.11.2 Tekmira RNA-based Biopharmaceuticals Product Specification 3.11.3 Tekmira RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 RXi 3.12.1 RXi Company Profile 3.12.2 RXi RNA-based Biopharmaceuticals Product Specification 3.12.3 RXi RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Alnylam Pharmaceuticals 3.13.1 Alnylam Pharmaceuticals Company Profile 3.13.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Specification 3.13.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Silenseed 3.14.1 Silenseed Company Profile 3.14.2 Silenseed RNA-based Biopharmaceuticals Product Specification 3.14.3 Silenseed RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 Senesco 3.15.1 Senesco Company Profile 3.15.2 Senesco RNA-based Biopharmaceuticals Product Specification 3.15.3 Senesco RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.16 Silence Therapeutics 3.16.1 Silence Therapeutics Company Profile 3.16.2 Silence Therapeutics RNA-based Biopharmaceuticals Product Specification 3.16.3 Silence Therapeutics RNA-based Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global RNA-based Biopharmaceuticals Market Competition by Market Players 4.1 Global RNA-based Biopharmaceuticals Production Capacity Market Share by Market Players (2015-2020) 4.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Market Players (2015-2020) 4.3 Global RNA-based Biopharmaceuticals Average Price by Market Players (2015-2020) 5 Global RNA-based Biopharmaceuticals Production by Regions (2015-2020) 5.1 North America 5.1.1 North America RNA-based Biopharmaceuticals Market Size (2015-2020) 5.1.2 RNA-based Biopharmaceuticals Key Players in North America (2015-2020) 5.1.3 North America RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.1.4 North America RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia RNA-based Biopharmaceuticals Market Size (2015-2020) 5.2.2 RNA-based Biopharmaceuticals Key Players in East Asia (2015-2020) 5.2.3 East Asia RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.2.4 East Asia RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe RNA-based Biopharmaceuticals Market Size (2015-2020) 5.3.2 RNA-based Biopharmaceuticals Key Players in Europe (2015-2020) 5.3.3 Europe RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.3.4 Europe RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia RNA-based Biopharmaceuticals Market Size (2015-2020) 5.4.2 RNA-based Biopharmaceuticals Key Players in South Asia (2015-2020) 5.4.3 South Asia RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.4.4 South Asia RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia RNA-based Biopharmaceuticals Market Size (2015-2020) 5.5.2 RNA-based Biopharmaceuticals Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.5.4 Southeast Asia RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East RNA-based Biopharmaceuticals Market Size (2015-2020) 5.6.2 RNA-based Biopharmaceuticals Key Players in Middle East (2015-2020) 5.6.3 Middle East RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.6.4 Middle East RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa RNA-based Biopharmaceuticals Market Size (2015-2020) 5.7.2 RNA-based Biopharmaceuticals Key Players in Africa (2015-2020) 5.7.3 Africa RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.7.4 Africa RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania RNA-based Biopharmaceuticals Market Size (2015-2020) 5.8.2 RNA-based Biopharmaceuticals Key Players in Oceania (2015-2020) 5.8.3 Oceania RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.8.4 Oceania RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America RNA-based Biopharmaceuticals Market Size (2015-2020) 5.9.2 RNA-based Biopharmaceuticals Key Players in South America (2015-2020) 5.9.3 South America RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.9.4 South America RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World RNA-based Biopharmaceuticals Market Size (2015-2020) 5.10.2 RNA-based Biopharmaceuticals Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World RNA-based Biopharmaceuticals Market Size by Type (2015-2020) 5.10.4 Rest of the World RNA-based Biopharmaceuticals Market Size by Application (2015-2020) 6 Global RNA-based Biopharmaceuticals Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America RNA-based Biopharmaceuticals Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia RNA-based Biopharmaceuticals Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe RNA-based Biopharmaceuticals Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia RNA-based Biopharmaceuticals Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia RNA-based Biopharmaceuticals Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East RNA-based Biopharmaceuticals Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa RNA-based Biopharmaceuticals Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania RNA-based Biopharmaceuticals Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America RNA-based Biopharmaceuticals Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World RNA-based Biopharmaceuticals Consumption by Countries 7 Global RNA-based Biopharmaceuticals Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of RNA-based Biopharmaceuticals (2021-2026) 7.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals (2021-2026) 7.3 Global Forecasted Price of RNA-based Biopharmaceuticals (2021-2026) 7.4 Global Forecasted Production of RNA-based Biopharmaceuticals by Region (2021-2026) 7.4.1 North America RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.2 East Asia RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.3 Europe RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.4 South Asia RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.6 Middle East RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.7 Africa RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.8 Oceania RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.9 South America RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World RNA-based Biopharmaceuticals Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of RNA-based Biopharmaceuticals by Application (2021-2026) 8 Global RNA-based Biopharmaceuticals Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.2 East Asia Market Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.3 Europe Market Forecasted Consumption of RNA-based Biopharmaceuticals by Countriy 8.4 South Asia Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.5 Southeast Asia Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.6 Middle East Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.7 Africa Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.8 Oceania Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.9 South America Forecasted Consumption of RNA-based Biopharmaceuticals by Country 8.10 Rest of the world Forecasted Consumption of RNA-based Biopharmaceuticals by Country 9 Global RNA-based Biopharmaceuticals Sales by Type (2015-2026) 9.1 Global RNA-based Biopharmaceuticals Historic Market Size by Type (2015-2020) 9.2 Global RNA-based Biopharmaceuticals Forecasted Market Size by Type (2021-2026) 10 Global RNA-based Biopharmaceuticals Consumption by Application (2015-2026) 10.1 Global RNA-based Biopharmaceuticals Historic Market Size by Application (2015-2020) 10.2 Global RNA-based Biopharmaceuticals Forecasted Market Size by Application (2021-2026) 11 Global RNA-based Biopharmaceuticals Manufacturing Cost Analysis 11.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals 12 Global RNA-based Biopharmaceuticals Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 RNA-based Biopharmaceuticals Distributors List 12.3 RNA-based Biopharmaceuticals Customers 12.4 RNA-based Biopharmaceuticals Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 115 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Consumer Goods and Retail | Pages : 174 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Chemicals and Materials | Pages : 121 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Energy, Mining and Utilities | Pages : 233 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 154 |
We will be happy to help you find what you need. Please call us or write to us: